ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Invesco Variable Rate Preferred ETF

Invesco Variable Rate Preferred ETF (VRP)

24.15
-0.03
(-0.12%)
At close: January 10 4:00PM
24.15
0.00
( 0.00% )
After Hours: 4:15PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
24.15
Bid
-
Ask
-
Volume
574,553
24.13 Day's Range 24.1953
23.1429 52 Week Range 24.67
Market Cap
Previous Close
24.18
Open
24.17
Last Trade
981
@
24.15
Last Trade Time
16:10:00
Financial Volume
$ 13,880,482
VWAP
24.1588
Average Volume (3m)
385,285
Shares Outstanding
72,100,000
Dividend Yield
-
PE Ratio
8.70
Earnings Per Share (EPS)
2.77
Revenue
95.49M
Net Profit
200.05M

About Invesco Variable Rate Preferred ETF

The investment seeks to track the investment results (before fees and expenses) of the Wells Fargo Hybrid and Preferred Securities Floating and Variable Rate Index. The fund will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is a m... The investment seeks to track the investment results (before fees and expenses) of the Wells Fargo Hybrid and Preferred Securities Floating and Variable Rate Index. The fund will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is a market capitalization-weighted index designed to track the performance of preferred stock, as well as certain types of hybrid securities that are functionally equivalent to preferred stocks, that are issued by U.S.-based or foreign issuers and that pay a floating or variable rate dividend or coupon. It is non-diversified. Show more

Sector
Mgmt Invt Offices, Open-end
Industry
Mgmt Invt Offices, Open-end
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Invesco Variable Rate Preferred ETF is listed in the Mgmt Invt Offices, Open-end sector of the American Stock Exchange with ticker VRP. The last closing price for Invesco Variable Rate Pr... was $24.18. Over the last year, Invesco Variable Rate Pr... shares have traded in a share price range of $ 23.1429 to $ 24.67.

Invesco Variable Rate Pr... currently has 72,100,000 shares outstanding. The market capitalization of Invesco Variable Rate Pr... is $1.74 billion. Invesco Variable Rate Pr... has a price to earnings ratio (PE ratio) of 8.70.

VRP Latest News

Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update

LONDON and RALEIGH, N.C., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

CORRECTING and REPLACING -- Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD

LONDON and RALEIGH, N.C., Feb. 02, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Verona Pharma plc (Nasdaq: VRNA), please note that all instances of the...

Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD

Primary and secondary lung function endpoints met Results support twice-daily dosing LONDON and RALEIGH, N.C., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona...

Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19

LONDON and RALEIGH, N.C., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

Verona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference

LONDON and RALEIGH, N.C., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

Verona Pharma Announces November 2020 Virtual Investor Conference Participation

LONDON and RALEIGH, N.C., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020

Initiated ENHANCE Phase 3 clinical trials in COPD Completed $200 million private placement Commenced a pilot clinical study in U.S. patients hospitalized with COVID-19 Conference call today at...

Verona Pharma to Announce Interim Results for the Three and Nine Months Ended September 30, 2020 and Provide Corporate Update...

LONDON and RALEIGH, N.C., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory...

Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020

LONDON and RALEIGH, N.C., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory...

Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19

LONDON and RALEIGH, N.C., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.14-0.57636887608124.2924.4524.1261877724.2612964SP
4-0.34-1.3883217639924.4924.5624.1255203524.29251037SP
12-0.52-2.1078232671324.6724.6724.1238528524.37592619SP
260.150.6252424.6723.4337833524.25897161SP
520.934.0051679586623.2224.6723.142937391923.97654086SP
156-1.63-6.3227307990725.7825.920.87543399823.19622836SP
260-1.79-6.9005397070225.9426.513.3340149323.74818793SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TIRXTian Ruixiang Holdings Ltd
$ 2.55
(52.69%)
1.68M
CJETChijet Motor Company Inc
$ 2.50
(23.15%)
165.39k
RAYRaytech Holding Ltd
$ 1.61
(19.26%)
317.91k
EHGOEshallgo Inc
$ 3.75
(14.68%)
687
SNTSenstar Technologies Ltd
$ 3.5853
(10.32%)
155
INTSIntesity Therapeutics Inc
$ 1.90
(-11.53%)
248
VMARVision Marine Technologies Inc
$ 1.92
(-10.70%)
881.1k
FAMIFarmmi Inc
$ 0.3304
(-9.92%)
266.04k
XTKGX3 Holdings Company Ltd
$ 1.25
(-8.76%)
4.08k
TLSATiziana Life Sciences Ltd
$ 0.7679
(-8.58%)
63.45k
CDTConduit Pharmaceuticals Inc
$ 0.1169
(-5.19%)
3.75M
NVDANVIDIA Corporation
$ 136.00
(0.07%)
2.96M
PSIGPS International Group Ltd
$ 0.5688
(7.52%)
2.14M
RGTIRigetti Computing Inc
$ 8.56
(-4.14%)
1.84M
TIRXTian Ruixiang Holdings Ltd
$ 2.55
(52.69%)
1.68M

Discussion

View Full Feed
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 5 minutes ago
Wow, here you go 🍼🍼
AVXL
SierraPacificRising SierraPacificRising 5 minutes ago
That dudes fake account is hilarious! I try to drag him and his comedy out as much as possible!!
FNMA
Gmenfan Gmenfan 5 minutes ago
Calif: Democrats Convene Special Session To ‘Trump-Proof’ State During Raging Fires: ‘More Focused On Trump Than Helping Residents’

The TDS is strong in these libtards:

https://www.oann.com/newsroom/calif-democrats-convene-special-session-to-trump-proof-state-during-r
Rattlershehe Rattlershehe 5 minutes ago
No, Neither company that is in the PR has been able to be found..
KRTL
Tdeank1 Tdeank1 5 minutes ago
Love the cards thst come on after a drop staring they sold at the high months ago
....no one cares...and everyone knows you are lying....because only a liar would post this swill

Cheers!!!
COOP
ProfitChaser ProfitChaser 6 minutes ago
MRES closed at .023. Making new 52wk highs. Been in this one for awhile.
MRES
igotthemojo igotthemojo 6 minutes ago
Careful of your weak heart sweetie…that’s why you left..you had such delicate sensibilities…

Best you just stay away…we get enough dead wrong prognostications from hogwash…
FCEL
MVTKL MVTKL 6 minutes ago
I don't believe Blagman was trying to deceive i just thing sometimes things don't work out as planned. For that reason i am out.
https://www.yahoo.com/news/don-king-sued-promoter-seeking-214035351.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAEYr4Lqi
MWWC
Lord Barek Lord Barek 6 minutes ago
Thanks for the link Werbe - did not see that amongst all of the other great content on the site. We spoke with a Company rep earlier, who apologized for the one broken link on the website. He said they are adding new information to the Investors page, as they are finalizing a new plan for funding
ATWT
getmoreshares getmoreshares 6 minutes ago
what page of the filing do you see that info?
CGAC
Golden Cross Golden Cross 7 minutes ago
Heading for a strong 2025 here...
BIEL
duelittle2 duelittle2 7 minutes ago
Weekly Trade Volume _ Will try to post each eow for comparison to Weekly O/S Changes

https://schrts.co/vrAdBZCC
TKMO
BIOCHEMUP BIOCHEMUP 7 minutes ago
I'm so done with OTC lol, small caps nasdaq is so much more fun. I always throught 7.5B market cap for SOUN was a little bit too much tho. 
SOUN
ProfitChaser ProfitChaser 7 minutes ago
Thanks. Enjoy yours also. Great day today. I dont have any RLAB. I will have to take a peek
RLAB
linkvest linkvest 7 minutes ago
About 1 million traded at .00045
ASII
Risk vs Reward Risk vs Reward 7 minutes ago
Is that what that red is ? I thought they only go up 
KULR
Dennboy66 Dennboy66 7 minutes ago
Sold. Took a small loss. Did not like the price action. The ask was AGGRESSIVELY loaded to drive price down. It appears that with the new admin that Bios will continue downward. 6.50 is a nice fib retracement. But today was not the day. There is ALOT of money to be made here. Just not today. Ma
IOVA
SierraPacificRising SierraPacificRising 8 minutes ago
With the growing concern over your financial situation it is advisable for you to hand over your assets to cousin Arnold to conserve and protect under a "temporary conservatorship". If the once most highly respected trader has more predictions like these he will again be forced into bankruptcy. 
FNMA
m0n m0n 8 minutes ago
reward? revenue? that's wishful thinking and hypothetical statements.  Remember your millions in revenue will come after the first feedlot???  That was 1.2 years ago!!!!

No One is Fooled 
IFUS
ProfitChaser ProfitChaser 8 minutes ago
I agree. Lots of green today for me.
Natural Trader Natural Trader 8 minutes ago
$GRYP added more volume up before the price
GRYP
gawti88 gawti88 8 minutes ago
This is facts. Boom!
CEOS
martyDg martyDg 9 minutes ago
When are we going to start the new MHRA approval prediction? There are only 11 months left until 2026. Should we extend the prediction to include 2026?
NWBO
Explosivo Explosivo 9 minutes ago
Comparing what happened in a COVID geared market is not really comparing apples to apples. The stimulus was a steroid injection straight into the market. You had mega eyes on GME, stocks were trending, etc. that money is no longer. Have you seen today’s economy? No one has disposable income. Just sa
GME
nowwhat2 nowwhat2 9 minutes ago
Blurred for you then but not me


https://investorshub.advfn.com/uimage/uploads/2025/1/10/wftxhXRP_!_10_6M_7am_chan_wedge_plain.jpg


https://investorshub.advfn.com/uimage/uploads/2025/1/10/jrnylXRP_!_10_1pm_3m_GLITCH_WEDGE_UPDATE.jpg


XRPUSD

Your Recent History

Delayed Upgrade Clock